Avisi Technologies: Valuation, Funding & Investors
Avisi Technologies is an ophthalmic medical device company developing novel sight-saving technologies for glaucoma treatment. The company is advancing VisiPlate®, a next-generation shunt featuring a unique metamaterial design that is thinner than a human hair and is being evaluated in the SAPPHIRE pivotal clinical trial.
Leadership & Board
- Current Number of Employees
- 16
- Current LinkedIn Followers
- 5,972
Latest Estimated Valuation
- Total Amount Raised
- $11M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $11M
- Latest Funding Round
- Series A
Employee Trend
Avisi Technologies had 16 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
16Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Avisi Technologies had 5,972 followers as of October 26, 2026. The number of followers increased by 16 (0.27%) week-over-week.
5,972Latest Followers Count
16(0.27%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Feb 25, 2026 | Series A | $10.70M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Accanto Partners | Series A |
| Golden Seeds LLC | Series A |
| Good Growth Capital | Series A |
| Life Sciences Greenhouse Investment | Series A |
| MedVenture Partners | Series A |
| OneOneFive | Series A |
| Quaker Capital Investments | Series A |
| SBI US Gateway Fund | Series A |
Similar Companies
A snapshot of private companies similar to Avisi Technologies, helping you discover and navigate related company profiles.
Related News and Analysis
